Rellim Capital Management

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2023	Orbital Therapeutics	$270.0M Series A	ARCH Venture Partners	Andreessen Horowitz, Nextech Invest, Section 32, Versant Ventures, a16z Bio + Health, Abu Dhabi Growth Fund, Agent Capital, Alexandria Venture Investments, Casdin Capital, Exor, Heritage Medical Systems, iGlobe Partners, Invus, Newpath Partners, Redmile Group

Total Raised

N/A

Valuation

N/A